APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Nuclide Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Medical Nuclide Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchMedical Nuclide Products Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Nuclide Products Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Medical Nuclide Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Nuclide Products Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Nuclide Products Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Medical Nuclide Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Medical Nuclide Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Nuclide Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Nuclide Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Medical Nuclide Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medical Nuclide Products include China Isotope & Radiation, Dongcheng Pharma, Eli Lilly, Junan Pharmaceutical, Bayer, Siemens, Q BioMed, Progenics Pharmaceuticals and Polatom, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Medical Nuclide Products market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Nuclide Products and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Nuclide Products revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Nuclide Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Nuclide Products Segment by Company

China Isotope & Radiation

Dongcheng Pharma

Eli Lilly

Junan Pharmaceutical

Bayer

Siemens

Q BioMed

Progenics Pharmaceuticals

Polatom

NTP Radioisotopes

NRG

Novartis International AG

Nordion

Mundipharma

Monrol

Lantheus Medical Imaging, Inc.

Jubilant Life Sciences

International Isotopes

GE Healthcare

Eckert & Ziegler Strahlen

Curium Pharma

Cardinal Health

Bracco Imaging

Aurobindo Pharma

ANSTO

Acrotech Biopharma.

Medical Nuclide Products Segment by Type

Radiopharmaceuticals

Radioactive Sources

Medical Diagnostic Nuclides

Others

Medical Nuclide Products Segment by Application

Hematological Diseases

Cardiovascular Diseases

Bone and Joint Diseases

Cancer

Others

Medical Nuclide Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Nuclide Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Nuclide Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Nuclide Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Nuclide Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Nuclide Products industry.

Chapter 3: Detailed analysis of Medical Nuclide Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Nuclide Productsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Nuclide Products Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Radiopharmaceuticals Table 3. Key Players of Radioactive Sources Table 4. Key Players of Medical Diagnostic Nuclides Table 3. Key Players of Others Table 4. Global Medical Nuclide Products Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hematological Diseases Table 6. Key Players of Cardiovascular Diseases Table 7. Key Players of Bone and Joint Diseases Table 8. Key Players of Cancer Table 9. Key Players of Others Table 10. Global Medical Nuclide Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Medical Nuclide Products Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Medical Nuclide Products Market Share by Region (2021-2026) Table 13. Global Medical Nuclide Products Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Medical Nuclide Products Market Share by Region (2027-2032) Table 15. Medical Nuclide Products Industry Trends Table 16. Medical Nuclide Products Industry Drivers Table 17. Medical Nuclide Products Industry Opportunities and Challenges Table 18. Medical Nuclide Products Industry Restraints Table 19. Global Medical Nuclide Products Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Medical Nuclide Products Revenue Market Share by Company (2021-2026) Table 21. Global Medical Nuclide Products Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Medical Nuclide Products Key Company Head Office and Area Served Table 23. Global Medical Nuclide Products Company, Product Type & Application Table 24. Global Medical Nuclide Products Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Medical Nuclide Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Medical Nuclide Products Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Medical Nuclide Products Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Medical Nuclide Products Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Medical Nuclide Products Revenue Market Share by Type (2021-2026) Table 31. Global Medical Nuclide Products Revenue Market Share by Type (2027-2032) Table 32. Global Medical Nuclide Products Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Medical Nuclide Products Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Medical Nuclide Products Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Medical Nuclide Products Revenue Market Share by Application (2021-2026) Table 36. Global Medical Nuclide Products Revenue Market Share by Application (2027-2032) Table 37. China Isotope & Radiation Company Information Table 38. China Isotope & Radiation Business Overview Table 39. China Isotope & Radiation Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. China Isotope & Radiation Medical Nuclide Products Product Portfolio Table 41. China Isotope & Radiation Recent Development Table 42. Dongcheng Pharma Company Information Table 43. Dongcheng Pharma Business Overview Table 44. Dongcheng Pharma Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Dongcheng Pharma Medical Nuclide Products Product Portfolio Table 46. Dongcheng Pharma Recent Development Table 47. Eli Lilly Company Information Table 48. Eli Lilly Business Overview Table 49. Eli Lilly Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Eli Lilly Medical Nuclide Products Product Portfolio Table 51. Eli Lilly Recent Development Table 52. Junan Pharmaceutical Company Information Table 53. Junan Pharmaceutical Business Overview Table 54. Junan Pharmaceutical Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Junan Pharmaceutical Medical Nuclide Products Product Portfolio Table 56. Junan Pharmaceutical Recent Development Table 57. Bayer Company Information Table 58. Bayer Business Overview Table 59. Bayer Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Bayer Medical Nuclide Products Product Portfolio Table 61. Bayer Recent Development Table 62. Siemens Company Information Table 63. Siemens Business Overview Table 64. Siemens Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Siemens Medical Nuclide Products Product Portfolio Table 66. Siemens Recent Development Table 67. Q BioMed Company Information Table 68. Q BioMed Business Overview Table 69. Q BioMed Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Q BioMed Medical Nuclide Products Product Portfolio Table 71. Q BioMed Recent Development Table 72. Progenics Pharmaceuticals Company Information Table 73. Progenics Pharmaceuticals Business Overview Table 74. Progenics Pharmaceuticals Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Progenics Pharmaceuticals Medical Nuclide Products Product Portfolio Table 76. Progenics Pharmaceuticals Recent Development Table 77. Polatom Company Information Table 78. Polatom Business Overview Table 79. Polatom Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Polatom Medical Nuclide Products Product Portfolio Table 81. Polatom Recent Development Table 82. NTP Radioisotopes Company Information Table 83. NTP Radioisotopes Business Overview Table 84. NTP Radioisotopes Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. NTP Radioisotopes Medical Nuclide Products Product Portfolio Table 86. NTP Radioisotopes Recent Development Table 87. NRG Company Information Table 88. NRG Business Overview Table 89. NRG Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. NRG Medical Nuclide Products Product Portfolio Table 91. NRG Recent Development Table 92. Novartis International AG Company Information Table 93. Novartis International AG Business Overview Table 94. Novartis International AG Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Novartis International AG Medical Nuclide Products Product Portfolio Table 96. Novartis International AG Recent Development Table 97. Nordion Company Information Table 98. Nordion Business Overview Table 99. Nordion Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Nordion Medical Nuclide Products Product Portfolio Table 101. Nordion Recent Development Table 102. Mundipharma Company Information Table 103. Mundipharma Business Overview Table 104. Mundipharma Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Mundipharma Medical Nuclide Products Product Portfolio Table 106. Mundipharma Recent Development Table 107. Monrol Company Information Table 108. Monrol Business Overview Table 109. Monrol Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Monrol Medical Nuclide Products Product Portfolio Table 111. Monrol Recent Development Table 112. Lantheus Medical Imaging, Inc. Company Information Table 113. Lantheus Medical Imaging, Inc. Business Overview Table 114. Lantheus Medical Imaging, Inc. Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Lantheus Medical Imaging, Inc. Medical Nuclide Products Product Portfolio Table 116. Lantheus Medical Imaging, Inc. Recent Development Table 117. Jubilant Life Sciences Company Information Table 118. Jubilant Life Sciences Business Overview Table 119. Jubilant Life Sciences Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Jubilant Life Sciences Medical Nuclide Products Product Portfolio Table 121. Jubilant Life Sciences Recent Development Table 122. International Isotopes Company Information Table 123. International Isotopes Business Overview Table 124. International Isotopes Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. International Isotopes Medical Nuclide Products Product Portfolio Table 126. International Isotopes Recent Development Table 127. GE Healthcare Company Information Table 128. GE Healthcare Business Overview Table 129. GE Healthcare Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. GE Healthcare Medical Nuclide Products Product Portfolio Table 131. GE Healthcare Recent Development Table 132. Eckert & Ziegler Strahlen Company Information Table 133. Eckert & Ziegler Strahlen Business Overview Table 134. Eckert & Ziegler Strahlen Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Eckert & Ziegler Strahlen Medical Nuclide Products Product Portfolio Table 136. Eckert & Ziegler Strahlen Recent Development Table 137. Curium Pharma Company Information Table 138. Curium Pharma Business Overview Table 139. Curium Pharma Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 140. Curium Pharma Medical Nuclide Products Product Portfolio Table 141. Curium Pharma Recent Development Table 142. Cardinal Health Company Information Table 143. Cardinal Health Business Overview Table 144. Cardinal Health Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 145. Cardinal Health Medical Nuclide Products Product Portfolio Table 146. Cardinal Health Recent Development Table 147. Bracco Imaging Company Information Table 148. Bracco Imaging Business Overview Table 149. Bracco Imaging Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 150. Bracco Imaging Medical Nuclide Products Product Portfolio Table 151. Bracco Imaging Recent Development Table 152. Aurobindo Pharma Company Information Table 153. Aurobindo Pharma Business Overview Table 154. Aurobindo Pharma Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 155. Aurobindo Pharma Medical Nuclide Products Product Portfolio Table 156. Aurobindo Pharma Recent Development Table 157. ANSTO Company Information Table 158. ANSTO Business Overview Table 159. ANSTO Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 160. ANSTO Medical Nuclide Products Product Portfolio Table 161. ANSTO Recent Development Table 162. Acrotech Biopharma. Company Information Table 163. Acrotech Biopharma. Business Overview Table 164. Acrotech Biopharma. Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 165. Acrotech Biopharma. Medical Nuclide Products Product Portfolio Table 166. Acrotech Biopharma. Recent Development Table 167. North America Medical Nuclide Products Market Size by Type (2021-2026) & (US$ Million) Table 168. North America Medical Nuclide Products Market Size by Type (2027-2032) & (US$ Million) Table 169. North America Medical Nuclide Products Market Size by Application (2021-2026) & (US$ Million) Table 170. North America Medical Nuclide Products Market Size by Application (2027-2032) & (US$ Million) Table 171. North America Medical Nuclide Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. North America Medical Nuclide Products Market Size by Country (2021-2026) Table 173. North America Medical Nuclide Products Market Size by Country (2027-2032) Table 174. Europe Medical Nuclide Products Market Size by Type (2021-2026) & (US$ Million) Table 175. Europe Medical Nuclide Products Market Size by Type (2027-2032) & (US$ Million) Table 176. Europe Medical Nuclide Products Market Size by Application (2021-2026) & (US$ Million) Table 177. Europe Medical Nuclide Products Market Size by Application (2027-2032) & (US$ Million) Table 178. Europe Medical Nuclide Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Medical Nuclide Products Market Size by Country (2021-2026) Table 180. Europe Medical Nuclide Products Market Size by Country (2027-2032) Table 181. China Medical Nuclide Products Market Size by Type (2021-2026) & (US$ Million) Table 182. China Medical Nuclide Products Market Size by Type (2027-2032) & (US$ Million) Table 183. China Medical Nuclide Products Market Size by Application (2021-2026) & (US$ Million) Table 184. China Medical Nuclide Products Market Size by Application (2027-2032) & (US$ Million) Table 185. Asia Medical Nuclide Products Market Size by Type (2021-2026) & (US$ Million) Table 186. Asia Medical Nuclide Products Market Size by Type (2027-2032) & (US$ Million) Table 187. Asia Medical Nuclide Products Market Size by Application (2021-2026) & (US$ Million) Table 188. Asia Medical Nuclide Products Market Size by Application (2027-2032) & (US$ Million) Table 189. Asia Medical Nuclide Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Medical Nuclide Products Market Size by Country (2021-2026) Table 191. Asia Medical Nuclide Products Market Size by Country (2027-2032) Table 192. South America, Middle East & Africa Medical Nuclide Products Market Size by Type (2021-2026) & (US$ Million) Table 193. South America, Middle East & Africa Medical Nuclide Products Market Size by Type (2027-2032) & (US$ Million) Table 194. South America, Middle East & Africa Medical Nuclide Products Market Size by Application (2021-2026) & (US$ Million) Table 195. South America, Middle East & Africa Medical Nuclide Products Market Size by Application (2027-2032) & (US$ Million) Table 196. South America, Middle East & Africa Medical Nuclide Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. South America, Middle East & Africa Medical Nuclide Products Market Size by Country (2021-2026) Table 198. South America, Middle East & Africa Medical Nuclide Products Market Size by Country (2027-2032) Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Medical Nuclide Products Product Image Figure 2. Global Medical Nuclide Products Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Medical Nuclide Products Market Share by Type: 2025 VS 2032 Figure 4. Radiopharmaceuticals Image Figure 5. Radioactive Sources Image Figure 6. Medical Diagnostic Nuclides Image Figure 7. Others Image Figure 8. Global Medical Nuclide Products Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Medical Nuclide Products Market Share by Application: 2025 VS 2032 Figure 10. Hematological Diseases Image Figure 11. Cardiovascular Diseases Image Figure 12. Bone and Joint Diseases Image Figure 13. Cancer Image Figure 14. Others Image Figure 15. Global Medical Nuclide Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 17. Global Medical Nuclide Products Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Medical Nuclide Products Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Medical Nuclide Products Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Medical Nuclide Products Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Medical Nuclide Products Revenue Market Share by Type (2021-2032) Figure 24. Global Medical Nuclide Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Medical Nuclide Products Revenue Market Share by Application (2021-2032) Figure 26. North America Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 27. North America Medical Nuclide Products Market Share by Type (2021-2032) Figure 28. North America Medical Nuclide Products Market Share by Application (2021-2032) Figure 29. North America Medical Nuclide Products Market Share by Country (2021-2032) Figure 30. United States Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 31. Canada Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 33. Europe Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 34. Europe Medical Nuclide Products Market Share by Type (2021-2032) Figure 35. Europe Medical Nuclide Products Market Share by Application (2021-2032) Figure 36. Europe Medical Nuclide Products Market Share by Country (2021-2032) Figure 37. Germany Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 38. France Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 40. Italy Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 41. Russia Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 43. China Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 44. China Medical Nuclide Products Market Share by Type (2021-2032) Figure 45. China Medical Nuclide Products Market Share by Application (2021-2032) Figure 46. Asia Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 47. Asia Medical Nuclide Products Market Share by Type (2021-2032) Figure 48. Asia Medical Nuclide Products Market Share by Application (2021-2032) Figure 49. Asia Medical Nuclide Products Market Share by Country (2021-2032) Figure 50. Japan Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 54. India Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 55. Australia Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Medical Nuclide Products Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Medical Nuclide Products Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Medical Nuclide Products Market Share by Country (2021-2032) Figure 60. Brazil Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 65. UAE Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 67. Chile Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Radiopharmaceuticals
  • Radioactive Sources
  • Medical Diagnostic Nuclides
  • Others
Applications
  • Hematological Diseases
  • Cardiovascular Diseases
  • Bone and Joint Diseases
  • Cancer
  • Others
Companies covered
  • China Isotope & Radiation
  • Dongcheng Pharma
  • Eli Lilly
  • Junan Pharmaceutical
  • Bayer
  • Siemens
  • Q BioMed
  • Progenics Pharmaceuticals
  • Polatom
  • NTP Radioisotopes
  • NRG
  • Novartis International AG
  • Nordion
  • Mundipharma
  • Monrol
  • Lantheus Medical Imaging, Inc.
  • Jubilant Life Sciences
  • International Isotopes
  • GE Healthcare
  • Eckert & Ziegler Strahlen
  • Curium Pharma
  • Cardinal Health
  • Bracco Imaging
  • Aurobindo Pharma
  • ANSTO
  • Acrotech Biopharma.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Medical Nuclide Products Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Radiopharmaceuticals
  5. 1.2.3 Radioactive Sources
  6. 1.2.4 Medical Diagnostic Nuclides
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Medical Nuclide Products Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hematological Diseases
  11. 1.3.3 Cardiovascular Diseases
  12. 1.3.4 Bone and Joint Diseases
  13. 1.3.5 Cancer
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Medical Nuclide Products Growth Trends by Region
  17. 1.5.1 Global Medical Nuclide Products Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Medical Nuclide Products Market Size by Region (2021-2026)
  19. 1.5.3 Medical Nuclide Products Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Medical Nuclide Products Market Dynamics
  1. 2.1 Medical Nuclide Products Industry Trends
  2. 2.2 Medical Nuclide Products Industry Drivers
  3. 2.3 Medical Nuclide Products Industry Opportunities and Challenges
  4. 2.4 Medical Nuclide Products Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Medical Nuclide Products Revenue by Company (2021-2026)
  2. 3.2 Global Medical Nuclide Products Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Medical Nuclide Products Key Company Head office and Area Served
  4. 3.4 Global Medical Nuclide Products Company, Product Type & Application
  5. 3.5 Global Medical Nuclide Products Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Medical Nuclide Products Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Medical Nuclide Products Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Medical Nuclide Products Tier 1, Tier 2, and Tier 3
4 Medical Nuclide Products Market by Type
  1. 4.1 Global Medical Nuclide Products Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Medical Nuclide Products Market Size by Type (2021-2032)
  3. 4.3 Global Medical Nuclide Products Market Size Share by Type (2021-2032)
5 Medical Nuclide Products Market by Application
  1. 5.1 Global Medical Nuclide Products Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Nuclide Products Market Size by Application (2021-2032)
  3. 5.3 Global Medical Nuclide Products Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 China Isotope & Radiation
  2. 6.1.1 China Isotope & Radiation Company Information
  3. 6.1.2 China Isotope & Radiation Business Overview
  4. 6.1.3 China Isotope & Radiation Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 China Isotope & Radiation Medical Nuclide Products Product Portfolio
  6. 6.1.5 China Isotope & Radiation Recent Developments
  7. 6.2 Dongcheng Pharma
  8. 6.2.1 Dongcheng Pharma Company Information
  9. 6.2.2 Dongcheng Pharma Business Overview
  10. 6.2.3 Dongcheng Pharma Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Dongcheng Pharma Medical Nuclide Products Product Portfolio
  12. 6.2.5 Dongcheng Pharma Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eli Lilly Medical Nuclide Products Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Junan Pharmaceutical
  20. 6.4.1 Junan Pharmaceutical Company Information
  21. 6.4.2 Junan Pharmaceutical Business Overview
  22. 6.4.3 Junan Pharmaceutical Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Junan Pharmaceutical Medical Nuclide Products Product Portfolio
  24. 6.4.5 Junan Pharmaceutical Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bayer Medical Nuclide Products Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Siemens
  32. 6.6.1 Siemens Company Information
  33. 6.6.2 Siemens Business Overview
  34. 6.6.3 Siemens Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Siemens Medical Nuclide Products Product Portfolio
  36. 6.6.5 Siemens Recent Developments
  37. 6.7 Q BioMed
  38. 6.7.1 Q BioMed Company Information
  39. 6.7.2 Q BioMed Business Overview
  40. 6.7.3 Q BioMed Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Q BioMed Medical Nuclide Products Product Portfolio
  42. 6.7.5 Q BioMed Recent Developments
  43. 6.8 Progenics Pharmaceuticals
  44. 6.8.1 Progenics Pharmaceuticals Company Information
  45. 6.8.2 Progenics Pharmaceuticals Business Overview
  46. 6.8.3 Progenics Pharmaceuticals Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Progenics Pharmaceuticals Medical Nuclide Products Product Portfolio
  48. 6.8.5 Progenics Pharmaceuticals Recent Developments
  49. 6.9 Polatom
  50. 6.9.1 Polatom Company Information
  51. 6.9.2 Polatom Business Overview
  52. 6.9.3 Polatom Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Polatom Medical Nuclide Products Product Portfolio
  54. 6.9.5 Polatom Recent Developments
  55. 6.10 NTP Radioisotopes
  56. 6.10.1 NTP Radioisotopes Company Information
  57. 6.10.2 NTP Radioisotopes Business Overview
  58. 6.10.3 NTP Radioisotopes Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 NTP Radioisotopes Medical Nuclide Products Product Portfolio
  60. 6.10.5 NTP Radioisotopes Recent Developments
  61. 6.11 NRG
  62. 6.11.1 NRG Company Information
  63. 6.11.2 NRG Business Overview
  64. 6.11.3 NRG Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 NRG Medical Nuclide Products Product Portfolio
  66. 6.11.5 NRG Recent Developments
  67. 6.12 Novartis International AG
  68. 6.12.1 Novartis International AG Company Information
  69. 6.12.2 Novartis International AG Business Overview
  70. 6.12.3 Novartis International AG Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Novartis International AG Medical Nuclide Products Product Portfolio
  72. 6.12.5 Novartis International AG Recent Developments
  73. 6.13 Nordion
  74. 6.13.1 Nordion Company Information
  75. 6.13.2 Nordion Business Overview
  76. 6.13.3 Nordion Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Nordion Medical Nuclide Products Product Portfolio
  78. 6.13.5 Nordion Recent Developments
  79. 6.14 Mundipharma
  80. 6.14.1 Mundipharma Company Information
  81. 6.14.2 Mundipharma Business Overview
  82. 6.14.3 Mundipharma Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Mundipharma Medical Nuclide Products Product Portfolio
  84. 6.14.5 Mundipharma Recent Developments
  85. 6.15 Monrol
  86. 6.15.1 Monrol Company Information
  87. 6.15.2 Monrol Business Overview
  88. 6.15.3 Monrol Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Monrol Medical Nuclide Products Product Portfolio
  90. 6.15.5 Monrol Recent Developments
  91. 6.16 Lantheus Medical Imaging, Inc.
  92. 6.16.1 Lantheus Medical Imaging, Inc. Company Information
  93. 6.16.2 Lantheus Medical Imaging, Inc. Business Overview
  94. 6.16.3 Lantheus Medical Imaging, Inc. Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Lantheus Medical Imaging, Inc. Medical Nuclide Products Product Portfolio
  96. 6.16.5 Lantheus Medical Imaging, Inc. Recent Developments
  97. 6.17 Jubilant Life Sciences
  98. 6.17.1 Jubilant Life Sciences Company Information
  99. 6.17.2 Jubilant Life Sciences Business Overview
  100. 6.17.3 Jubilant Life Sciences Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Jubilant Life Sciences Medical Nuclide Products Product Portfolio
  102. 6.17.5 Jubilant Life Sciences Recent Developments
  103. 6.18 International Isotopes
  104. 6.18.1 International Isotopes Company Information
  105. 6.18.2 International Isotopes Business Overview
  106. 6.18.3 International Isotopes Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 International Isotopes Medical Nuclide Products Product Portfolio
  108. 6.18.5 International Isotopes Recent Developments
  109. 6.19 GE Healthcare
  110. 6.19.1 GE Healthcare Company Information
  111. 6.19.2 GE Healthcare Business Overview
  112. 6.19.3 GE Healthcare Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 GE Healthcare Medical Nuclide Products Product Portfolio
  114. 6.19.5 GE Healthcare Recent Developments
  115. 6.20 Eckert & Ziegler Strahlen
  116. 6.20.1 Eckert & Ziegler Strahlen Company Information
  117. 6.20.2 Eckert & Ziegler Strahlen Business Overview
  118. 6.20.3 Eckert & Ziegler Strahlen Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Eckert & Ziegler Strahlen Medical Nuclide Products Product Portfolio
  120. 6.20.5 Eckert & Ziegler Strahlen Recent Developments
  121. 6.21 Curium Pharma
  122. 6.21.1 Curium Pharma Company Information
  123. 6.21.2 Curium Pharma Business Overview
  124. 6.21.3 Curium Pharma Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Curium Pharma Medical Nuclide Products Product Portfolio
  126. 6.21.5 Curium Pharma Recent Developments
  127. 6.22 Cardinal Health
  128. 6.22.1 Cardinal Health Company Information
  129. 6.22.2 Cardinal Health Business Overview
  130. 6.22.3 Cardinal Health Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Cardinal Health Medical Nuclide Products Product Portfolio
  132. 6.22.5 Cardinal Health Recent Developments
  133. 6.23 Bracco Imaging
  134. 6.23.1 Bracco Imaging Company Information
  135. 6.23.2 Bracco Imaging Business Overview
  136. 6.23.3 Bracco Imaging Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Bracco Imaging Medical Nuclide Products Product Portfolio
  138. 6.23.5 Bracco Imaging Recent Developments
  139. 6.24 Aurobindo Pharma
  140. 6.24.1 Aurobindo Pharma Company Information
  141. 6.24.2 Aurobindo Pharma Business Overview
  142. 6.24.3 Aurobindo Pharma Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Aurobindo Pharma Medical Nuclide Products Product Portfolio
  144. 6.24.5 Aurobindo Pharma Recent Developments
  145. 6.25 ANSTO
  146. 6.25.1 ANSTO Company Information
  147. 6.25.2 ANSTO Business Overview
  148. 6.25.3 ANSTO Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 ANSTO Medical Nuclide Products Product Portfolio
  150. 6.25.5 ANSTO Recent Developments
  151. 6.26 Acrotech Biopharma.
  152. 6.26.1 Acrotech Biopharma. Company Information
  153. 6.26.2 Acrotech Biopharma. Business Overview
  154. 6.26.3 Acrotech Biopharma. Medical Nuclide Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 Acrotech Biopharma. Medical Nuclide Products Product Portfolio
  156. 6.26.5 Acrotech Biopharma. Recent Developments
7 North America
  1. 7.1 North America Medical Nuclide Products Market Size (2021-2032)
  2. 7.2 North America Medical Nuclide Products Market Size by Type
  3. 7.2.1 North America Medical Nuclide Products Market Size by Type (2021-2026)
  4. 7.2.2 North America Medical Nuclide Products Market Size by Type (2027-2032)
  5. 7.2.3 North America Medical Nuclide Products Market Share by Type (2021-2032)
  6. 7.3 North America Medical Nuclide Products Market Size by Application
  7. 7.3.1 North America Medical Nuclide Products Market Size by Application (2021-2026)
  8. 7.3.2 North America Medical Nuclide Products Market Size by Application (2027-2032)
  9. 7.3.3 North America Medical Nuclide Products Market Share by Application (2021-2032)
  10. 7.4 North America Medical Nuclide Products Market Size by Country
  11. 7.4.1 North America Medical Nuclide Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Medical Nuclide Products Market Size by Country (2021-2026)
  13. 7.4.3 North America Medical Nuclide Products Market Size by Country (2027-2032)
  14. 7.4.4 North America Medical Nuclide Products Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Medical Nuclide Products Market Size (2021-2032)
  2. 8.2 Europe Medical Nuclide Products Market Size by Type
  3. 8.2.1 Europe Medical Nuclide Products Market Size by Type (2021-2026)
  4. 8.2.2 Europe Medical Nuclide Products Market Size by Type (2027-2032)
  5. 8.2.3 Europe Medical Nuclide Products Market Share by Type (2021-2032)
  6. 8.3 Europe Medical Nuclide Products Market Size by Application
  7. 8.3.1 Europe Medical Nuclide Products Market Size by Application (2021-2026)
  8. 8.3.2 Europe Medical Nuclide Products Market Size by Application (2027-2032)
  9. 8.3.3 Europe Medical Nuclide Products Market Share by Application (2021-2032)
  10. 8.4 Europe Medical Nuclide Products Market Size by Country
  11. 8.4.1 Europe Medical Nuclide Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Medical Nuclide Products Market Size by Country (2021-2026)
  13. 8.4.3 Europe Medical Nuclide Products Market Size by Country (2027-2032)
  14. 8.4.4 Europe Medical Nuclide Products Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Medical Nuclide Products Market Size (2021-2032)
  2. 9.2 China Medical Nuclide Products Market Size by Type
  3. 9.2.1 China Medical Nuclide Products Market Size by Type (2021-2026)
  4. 9.2.2 China Medical Nuclide Products Market Size by Type (2027-2032)
  5. 9.2.3 China Medical Nuclide Products Market Share by Type (2021-2032)
  6. 9.3 China Medical Nuclide Products Market Size by Application
  7. 9.3.1 China Medical Nuclide Products Market Size by Application (2021-2026)
  8. 9.3.2 China Medical Nuclide Products Market Size by Application (2027-2032)
  9. 9.3.3 China Medical Nuclide Products Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Medical Nuclide Products Market Size (2021-2032)
  2. 10.2 Asia Medical Nuclide Products Market Size by Type
  3. 10.2.1 Asia Medical Nuclide Products Market Size by Type (2021-2026)
  4. 10.2.2 Asia Medical Nuclide Products Market Size by Type (2027-2032)
  5. 10.2.3 Asia Medical Nuclide Products Market Share by Type (2021-2032)
  6. 10.3 Asia Medical Nuclide Products Market Size by Application
  7. 10.3.1 Asia Medical Nuclide Products Market Size by Application (2021-2026)
  8. 10.3.2 Asia Medical Nuclide Products Market Size by Application (2027-2032)
  9. 10.3.3 Asia Medical Nuclide Products Market Share by Application (2021-2032)
  10. 10.4 Asia Medical Nuclide Products Market Size by Country
  11. 10.4.1 Asia Medical Nuclide Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Medical Nuclide Products Market Size by Country (2021-2026)
  13. 10.4.3 Asia Medical Nuclide Products Market Size by Country (2027-2032)
  14. 10.4.4 Asia Medical Nuclide Products Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Medical Nuclide Products Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Medical Nuclide Products Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Medical Nuclide Products Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Medical Nuclide Products Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Medical Nuclide Products Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Medical Nuclide Products Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Medical Nuclide Products Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Medical Nuclide Products Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Medical Nuclide Products Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Medical Nuclide Products Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Medical Nuclide Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Medical Nuclide Products Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Medical Nuclide Products Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Medical Nuclide Products Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst